newsfilter
← Latest News
GlobeNewswire·

VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals

BASEL, Switzerland, June 26, 2023 (GLOBE NEWSWIRE) -- VectivBio Holding AG ("VectivBio") (NASDAQ:VECT), a global clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare